Skip to main content

Table 6 A few representative KEGG pathways for the putative target genes of the validated miRNAs

From: Comparative expression profiles of microRNA in left and right atrial appendages from patients with rheumatic mitral valve disease exhibiting sinus rhythm or atrial fibrillation

KEGG pathway

Target genes

miRNAs

TGF-beta signaling pathway

ACVR1C, INHBB,SMAD1, SMAD3, TGFBR2,ZFYVE9

miR-26a-5p, miR-145-5p

MAPK signaling pathway

KRAS, MAP3K7, DUSP6, FLNB, PPP3CA, PRKX, RASA1, TGFBR2,MAP4K4, RAPGEF2

miR-143-3p, miR-145-5p

mTORsignaling pathway

EIF4E

miR-4484

VEGF signaling pathway

KRAS, SHC2

miR-143-3p, miR-4484

Calcium signaling pathway

ADCY3

miR-4484

Wntsignaling pathway

PLCB1, FRAT2, GSK3B, PPP3CB

miR-26a-5p

Gap junction

KRAS, ADCY3

miR-143-3p, miR-4484

Regulation of actin cytoskeleton

PFN2, ITGA6, ITGB8, KRAS

miR-133b, miR-143-3p

Hypertrophic cardiomyopathy (HCM)

IGF1, TPM3, TPM4

miR-1

Tight junction

MPP5, RRAS2, VAPA, PPP2CB, KRAS

miR-1, miR-23b-3p, miR-133b, miR-143-3p

Arrhythmogenic right ventricular cardiomyopathy (ARVC)

GJA1, ITGA6, SGCB, ITGB8, ACTB, ACTG1

miR-1, miR-30c-5p, miR-145-5p